TAVR is the recommended option for elderly patients with high surgical risk, whereas open aortic valve replacement is better suited for younger patients with longer life expectancy and fewer underlying health conditions. In TAVR, a thin catheter is guided through the femoral artery to place the new valve, avoiding the need for a chest incision or a heart-lung machine. Open surgery, on the other hand, involves opening the chest and supporting circulation through a bypass machine during the procedure. The choice between the two depends on recovery time, procedural risk, valve longevity, and the patient’s overall health condition.
According to Dr. Vishal Khullar, Cardiac Surgeon in Mumbai, In patients above 75 with comorbidities, TAVR cuts mortality risk by nearly half compared to open surgery, but anatomy and valve longevity still weigh heavily on the final call.
Same valve, two completely different roads to get there.
Procedural Flow Comparison
SEVERE AORTIC STENOSIS DIAGNOSIS
│
Heart Team Evaluation
│
┌───────────────┴───────────────┐
▼ ▼
╔═══════════╗ ╔═══════════╗
║ TAVR ║ ║ OPEN AVR ║
╚═══════════╝ ╚═══════════╝
│ │
Conscious Sedation General Anesthesia
│ │
Femoral Artery Puncture Sternotomy (Chest Opening)
│ │
Catheter Insertion Heart-Lung Machine Connected
│ │
Valve Deployed via Catheter Heart Stopped, Old Valve Removed
│ │
Beating Heart Throughout New Valve Sutured In Place
│ │
Procedure Time: 1 to 2 hours Procedure Time: 3 to 4 hours
│ │
ICU Stay: 12 to 24 hours ICU Stay: 48 to 72 hours
│ │
Hospital Stay: 2 to 3 days Hospital Stay: 7 to 10 days
│ │
└───────────────┬───────────────┘
▼
Recovery & Follow-up
For a deeper look at the procedure itself, see TAVR – Transcatheter Aortic Valve Replacement.
Worried about going under the knife at this age?
Frailty changes everything. A 78-year-old with kidney disease and lung trouble doesn’t tolerate open surgery the way a fit 65-year-old does.
|
Outcome Metric |
TAVR |
Open AVR |
|
30-day mortality (high-risk) |
3 to 4% |
6 to 8% |
|
Stroke rate |
2 to 4% |
2 to 3% |
|
Permanent pacemaker need |
8 to 15% |
3 to 5% |
|
Valve durability |
5 to 10 years (data ongoing) |
15 to 20 years |
|
Return to normal activity |
1 to 2 weeks |
6 to 8 weeks |
So the call comes down to heart team evaluation. STS score, anatomy, what the patient actually wants out of recovery. For related reading, see End Stage of Congestive Heart Failure in the Elderly.
Dr. Vishal Khullar is the Director of Cardiovascular and Thoracic Surgery, Heart & Lung Transplant at Fortis Hospital Mulund and Fortis S L Raheja Hospital. Over 30 years in the field, 7,000+ surgeries done, plus prior tenure as Senior Associate Consultant at Mayo Clinic, Rochester. His range covers complex valve work, cardiac transplants, and high-risk redo surgeries that most centres won’t touch.
Every elderly case gets individual risk stratification, no shortcuts. The TAVR-versus-open call is made jointly with cardiology, never rushed, never one-size-fits-all. Patients fly in from across India and abroad for exactly that kind of judgment.
For high-risk elderly cases, TAVR shows lower 30-day mortality and faster recovery than open surgery.
Current data points to 5 to 10 years of solid function, with newer devices still under long-term study.
Many centres now use conscious sedation for suitable candidates, no general anesthesia needed.
TAVR patients typically go home in 2 to 3 days. Open surgery means 7 to 10 days minimum.
WhatsApp us

